Celyad - Company & Market Research Reports

Celyad SA, a clinical-stage biopharmaceutical company, focuses on engineered cell therapy treatments. It develops therapeutic therapies for the treatment of unmet medical needs in cardiology and oncology. The company's best known product is the C-Cure, an autologous cell therapy for the treatment of heart failure. The company was formerly known as Cardio3 BioSciences SA and changed its name to Celyad SA in May 2015. Celyad SA was founded in 2004 and is based in Mont-Saint-Guibert, Belgium.

From
From
From
From
From
From
From
The Global Market for Stem Cells - Product Thumbnail Image

The Global Market for Stem Cells

  • Report
  • 162 Pages
From
From
From
From
From
From
From
From
CAR-T Therapies Market, 2018-2030 - Product Thumbnail Image

CAR-T Therapies Market, 2018-2030

  • Report
  • 548 Pages
From
Drug analysis: C-Cure - Product Thumbnail Image

Drug analysis: C-Cure

  • Drug Pipelines
  • 15 Pages
From
From
Loading Indicator
adroll